Thomas J. Sayers

7.3k total citations
104 papers, 5.9k citations indexed

About

Thomas J. Sayers is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Thomas J. Sayers has authored 104 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 49 papers in Molecular Biology and 40 papers in Oncology. Recurrent topics in Thomas J. Sayers's work include Immune Cell Function and Interaction (35 papers), Cell death mechanisms and regulation (26 papers) and Immunotherapy and Immune Responses (26 papers). Thomas J. Sayers is often cited by papers focused on Immune Cell Function and Interaction (35 papers), Cell death mechanisms and regulation (26 papers) and Immunotherapy and Immune Responses (26 papers). Thomas J. Sayers collaborates with scholars based in United States, Australia and Japan. Thomas J. Sayers's co-authors include William J. Murphy, Alan D. Brooks, Mark J. Smyth, John R. Ortaldo, Robert H. Wiltrout, Dennis D. Taub, C R Carter, Anatoli Malyguine, Naoko Seki and Curtis J. Henrich and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Thomas J. Sayers

104 papers receiving 5.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas J. Sayers United States 45 3.1k 2.2k 1.7k 638 619 104 5.9k
Atsushi Muraguchi Japan 41 3.3k 1.1× 2.0k 0.9× 1.2k 0.7× 468 0.7× 399 0.6× 155 6.6k
Gerrit Koopman Netherlands 27 2.9k 0.9× 3.0k 1.4× 868 0.5× 606 0.9× 406 0.7× 98 7.0k
Daniel W. McVicar United States 56 7.2k 2.3× 2.6k 1.2× 2.8k 1.6× 1.1k 1.7× 659 1.1× 145 10.7k
David A. Hildeman United States 47 6.1k 2.0× 2.7k 1.2× 1.4k 0.8× 1.2k 1.9× 827 1.3× 126 9.3k
Thomas Geiger Germany 26 1.3k 0.4× 1.8k 0.8× 986 0.6× 641 1.0× 245 0.4× 70 4.6k
Donna L. Mendrick United States 34 2.4k 0.8× 2.4k 1.1× 547 0.3× 420 0.7× 629 1.0× 80 7.1k
Manfred Brockhaus Switzerland 49 5.1k 1.7× 3.9k 1.8× 1.4k 0.8× 898 1.4× 485 0.8× 83 10.2k
Wai‐Ping Fung‐Leung United States 44 5.2k 1.7× 2.7k 1.2× 1.0k 0.6× 613 1.0× 396 0.6× 82 8.2k
Johannes Stöckl Austria 39 2.9k 1.0× 2.0k 0.9× 1.5k 0.9× 521 0.8× 322 0.5× 93 5.9k
David J. Livingston United States 32 2.4k 0.8× 4.6k 2.1× 820 0.5× 672 1.1× 317 0.5× 54 6.7k

Countries citing papers authored by Thomas J. Sayers

Since Specialization
Citations

This map shows the geographic impact of Thomas J. Sayers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Sayers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Sayers more than expected).

Fields of papers citing papers by Thomas J. Sayers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Sayers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Sayers. The network helps show where Thomas J. Sayers may publish in the future.

Co-authorship network of co-authors of Thomas J. Sayers

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Sayers. A scholar is included among the top collaborators of Thomas J. Sayers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Sayers. Thomas J. Sayers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tewary, Poonam, Alan D. Brooks, Ya-Ming Xu, et al.. (2021). Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins. Cancer Research. 81(12). 3374–3386. 12 indexed citations
2.
Shanker, Anil, Samuel T. Pellom, Menaka C. Thounaojam, et al.. (2015). Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity. Cancer Research. 75(24). 5260–5272. 23 indexed citations
3.
Sayers, Thomas J., et al.. (2015). Impact of dietary components on NK and Treg cell function for cancer prevention. Molecular Carcinogenesis. 54(9). 669–678. 15 indexed citations
4.
Canter, Robert J., Erik Ames, Steven K. Grossenbacher, et al.. (2014). Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma. BMC Cancer. 14(1). 756–756. 20 indexed citations
5.
Mathews, Lesley, Jonathan M. Keller, Bonnie L. Goodwin, et al.. (2012). A 1536-Well Quantitative High-Throughput Screen to Identify Compounds Targeting Cancer Stem Cells. SLAS DISCOVERY. 17(9). 1231–1242. 27 indexed citations
6.
Brooks, Alan D., Kristen M. Jacobsen, Wenqing Li, Anil Shanker, & Thomas J. Sayers. (2010). Bortezomib Sensitizes Human Renal Cell Carcinomas to TRAIL Apoptosis through Increased Activation of Caspase-8 in the Death-Inducing Signaling Complex. Molecular Cancer Research. 8(5). 729–738. 54 indexed citations
7.
Shanker, Anil, Alan D. Brooks, Kristen M. Jacobsen, et al.. (2009). Antigen Presented by Tumors In vivo Determines the Nature of CD8+ T-Cell Cytotoxicity. Cancer Research. 69(16). 6615–6623. 38 indexed citations
8.
Khan, Tahira, Jimmy K. Stauffer, R. H. Williams, et al.. (2006). Proteasome Inhibition to Maximize the Apoptotic Potential of Cytokine Therapy for Murine Neuroblastoma Tumors. The Journal of Immunology. 176(10). 6302–6312. 30 indexed citations
9.
Takeda, Kazuyoshi, Noriko Yamaguchi, Hisaya Akiba, et al.. (2004). Induction of Tumor-specific T Cell Immunity by Anti-DR5 Antibody Therapy. The Journal of Experimental Medicine. 199(4). 437–448. 165 indexed citations
10.
Brooks, Alan D. & Thomas J. Sayers. (2004). Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis. Cancer Immunology Immunotherapy. 54(5). 499–505. 32 indexed citations
11.
Komatsu, Masanobu, Michele Mammolenti, Monica Jones, et al.. (2003). Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing. Blood. 101(10). 3991–3999. 27 indexed citations
12.
Murphy, William J., Timothy Back, Julie A. Hixon, et al.. (2003). Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8+ Cell Responses. The Journal of Immunology. 170(5). 2727–2733. 84 indexed citations
13.
Seki, Naoko, Alan D. Brooks, Clive R.D. Carter, et al.. (2002). Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin. The Journal of Immunology. 168(7). 3484–3492. 111 indexed citations
14.
Sayers, Thomas J., Alan D. Brooks, Jerrold M. Ward, et al.. (2001). The Restricted Expression of Granzyme M in Human Lymphocytes. The Journal of Immunology. 166(2). 765–771. 77 indexed citations
15.
Lee, Jong‐Keuk, Thomas J. Sayers, Alan D. Brooks, et al.. (2000). IFN-γ-Dependent Delay of In Vivo Tumor Progression by Fas Overexpression on Murine Renal Cancer Cells. The Journal of Immunology. 164(1). 231–239. 61 indexed citations
16.
Baker, Elizabeth, Thomas J. Sayers, Grant R. Sutherland, & Mark J. Smyth. (1994). The genes encoding NK cell granule serine proteases, human tryptase-2 (TRYP2) and human granzyme A (HFSP), both map to chromosome 5q11-q12 and define a new locus for cytotoxic lymphocyte granule tryptases. Immunogenetics. 40(3). 235–237. 27 indexed citations
17.
Smyth, Mark J., Thomas J. Sayers, T A Wiltrout, James C. Powers, & Joseph A. Trapani. (1993). Met-ase: cloning and distinct chromosomal location of a serine protease preferentially expressed in human natural killer cells.. The Journal of Immunology. 151(11). 6195–6205. 52 indexed citations
18.
Murphy, W J, Timothy Back, Kevin C. Conlon, et al.. (1993). Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.. Journal of Clinical Investigation. 92(4). 1918–1924. 38 indexed citations
19.
Sayers, Thomas J., Llewellyn H. Mason, & T A Wiltrout. (1990). Trafficking and activation of murine natural killer cells: Differing roles for IFN-γ and IL-2. Cellular Immunology. 127(2). 311–326. 17 indexed citations
20.
Pawelec, Graham, Thomas J. Sayers, & F.W. Busch. (1989). Regulation of normal myelopoiesis and chronic myelogenous leukaemia' cell proliferation through a non-cytotoxic mechanism by a γ/δ T cell clone☆. Immunology Letters. 22(3). 199–204. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026